Floatz logo

Rondaptivon pegol sodium

Intracranial Arteriosclerosis

Band Therapeuticsnucleic_acidPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Intracranial Arteriosclerosis cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Yonsei University
Phase 4BBB
Plavix
Yonsei University
Phase 4BB
Apixaban
Yonsei University
Phase 4BB
Rivaroxaban
University of Florida
Phase 3BB
Ticagrelor
University of Florida
Phase 3B

View all 14 →

Same molecule, other indications

Rondaptivon pegol sodium is also rated in:

hemophilia ADormant
CCC
Indicative ·
54 / 100
View asset →
stroke disorderDormant
CC
Indicative ·
47 / 100
View asset →
atherosclerosisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →